Bevacizumab plus FOLFIRI after failure of platinum-etoposide first-line chemotherapy in patients with advanced neuroendocrine carcinoma (PRODIGE 41-BEVANEC): a randomised, multicentre, non-comparative, open-label, phase 2 trial.

Walter, Thomas; Lievre, Astrid; Coriat, Romain; Malka, David; Elhajbi, Farid; Di Fiore, Fréderic; Hentic, Olivia; Smith, Denis; Hautefeuille, Vincent; Roquin, Guillaume; Perrier, Marine; Dahan, Laetitia; Granger, Victoire; Sobhani, Iradj; Mineur, Laurent; Niccoli, Patricia; Assenat, Eric; Scoazec, Jean-Yves; Le Malicot, Karine; Lepage, Côme; Lombard-Bohas, Catherine

Walter, Thomas; Lievre, Astrid; Coriat, Romain; Malka, David; Elhajbi, Farid; Di Fiore, Fréderic; Hentic, Olivia; Smith, Denis; Hautefeuille, Vincent; Roquin, Guillaume; Perrier, Marine; Dahan, Laetitia; Granger, Victoire; Sobhani, Iradj; Mineur, Laurent; Niccoli, Patricia; Assenat, Eric; Scoazec, Jean-Yves; Le Malicot, Karine; Lepage, Côme; Lombard-Bohas, Catherine.

Affiliation

Walter T; Department of Medical Oncology, Hôpital Edouard Herriot, Hospices Civils de Lyon, Lyon, France; Gastroenterology and Technologies for Health, Research Unit INSERM UMR 1052 CNRS UMR 5286, Cancer Research Center of Lyon, Lyon, France. Electronic address: thomas.walter@chu-lyon.fr.
Lievre A; Digestive Unit, Hôpital Universitaire de Pontchaillou, Rennes, France.
Coriat R; Gastroenterology Department, Hôpital Cochin, Paris, France.
Malka D; Gastrointestinal Oncology Department, Gustave Roussy, Villejuif, France.
Elhajbi F; Oncology Department, Centre Oscar Lambret, Lille, France.
Di Fiore F; Gastroenterology Department, Hôpital Universitaire de Rouen, Rouen, France.
Hentic O; Gastroenterology-Pancreatology Department, Hôpital Beaujon, Clichy, France.
Smith D; Hepatogastroenterology and Digestive Oncology, Hôpital Universitaire de Bordeaux, Pessac, France.
Hautefeuille V; Gastroenterology and Digestive Oncology, Hôpital Universitaire d'Amiens, Amiens, France.
Roquin G; Gastroenterology and Digestive Oncology, Hôpital Universitaire d'Angers, Angers, France.
Perrier M; Department of Hepatogastroenterology and Digestive Oncology, Hôpital Robert Debré, Reims, France.
Dahan L; Digestive Oncology Department, Hôpital Universitaire La Timone, Marseille, France.
Granger V; Hepatogastroenterology Department, Hôpital Universitaire Michallon, Grenoble, France.
Sobhani I; Department of Hepatogastroenterology and Digestive Oncology, Hôpital Henry Mondor, Creteil, France.
Mineur L; Oncology Department, Clinique Sainte-Catherine, Avignon, France.
Niccoli P; Oncology Department, Institut Paoli Calmette, Marseille, France.
Assenat E; Medical Oncology Department, Hôpital St Eloi, Montpellier, France.
Scoazec JY; Department of Surgical and Molecular Pathology, Gustave Roussy, Villejuif, France.
Le Malicot K; Fédération Francophone de Cancérologie Digestive, EPICAD INSERM LNC-UMR 1231, University of Burgundy and Franche Comté, Dijon, France.
Lepage C; Gastroenterology and Digestive Oncology, Hôpital Universitaire Le Bocage, Dijon, France.
Lombard-Bohas C; Department of Medical Oncology, Hospices Civils de Lyon, Lyon, France.

Lancet Oncol ; 24(3): 297-306, 2023 03.

Article de En | MEDLINE | ID: mdl-36739879

Sujet(s)

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Encéphalopathie ischémique / Carcinome neuroendocrine / Accident vasculaire cérébral / Neutropénie Type d'étude: Clinical_trials Limites: Aged / Female / Humans / Male / Middle aged Langue: En Journal: Lancet Oncol Sujet du journal: NEOPLASIAS Année: 2023 Type de document: Article

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google